Palatin Technologies
We discover and develop novel therapeutics for patients living with inflammatory and autoimmune conditions.
General Information
BounceWatch is an independent company data service, not affiliated with Palatin Technologies. To contact Palatin Technologies, visit palatin.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Palatin Technologies compare?
A PDF of Palatin Technologies and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Palatin Technologies soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
About Palatin Technologies
Business keywords: biopharmaceutical, therapeutics, medical research, melanocortin system, inflammatory conditions, autoimmune conditions, ophthalmic indications, clinical trials, FDA approval, premenopausal women's health, inflammatory disease treatment, drug development, investor relations, clinical studies
Funding Rounds & Investors (9)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post IPO Equity | $10.00M | - |
|
30 Jan 2024 |
| Post IPO Equity | $5.00M | - |
|
23 Oct 2023 |
| Grant | $4.70M | 1 |
|
18 Jan 2023 |
| Post IPO Equity | $10.00M | - |
|
31 Oct 2022 |
| Post IPO Equity | $16.50M | - |
|
08 Dec 2016 |
| Post IPO Equity | $20.00M | 1 |
|
24 Dec 2014 |
| Post IPO Debt | $10.00M | 1 |
|
24 Dec 2014 |
| Post IPO Equity | $35.00M | - |
|
13 Jul 2012 |
| Post IPO Equity | $22.70M | 8 |
|
30 Jan 2004 |
Palatin Technologies Alternatives & Competitors
View All Alternatives
Pioneering breakthrough treatments for autoimmune and inflammatory diseases with a focus on enhancin...
Developing lifesaving therapies for drug-resistant cancers and autoimmune diseases through innovativ...
We are a drug platform focused on treating autoimmune and inflammatory diseases.
FAQ About Palatin Technologies
Source: BounceWatch company record for Palatin Technologies, https://bouncewatch.com/company/palatin-technologies, updated 30 June 2026. When citing, please name BounceWatch and link this page.
